CLB
Overvalued by 42.7% based on the discounted cash flow analysis.
Market cap | $503.99 Million |
---|---|
Enterprise Value | $525.87 Million |
Dividend Yield | $0.04 (0.372093023255814%) |
Earnings per Share | $0.67 |
Beta | 1.45 |
Outstanding Shares | 46,773,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 17.94 |
---|---|
PEG | -17.12 |
Price to Sales | 1.0 |
Price to Book Ratio | 2.19 |
Enterprise Value to Revenue | 1.02 |
Enterprise Value to EBIT | 10.22 |
Enterprise Value to Net Income | 18 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | 0.17 |
No data
No data
Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...